CGON vs NRG · rev $4.0M vs P/E 145, rev $17.74B
CG Oncology, Inc. Common stock (CGON) versus NRG Energy Inc. (NRG) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
NRG Energy Inc. (NRG) is a utilities - independent power producers company listed on NYSE.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported NRG revenue for 2026-06-30 was $17.74B. Net income was $631.0M. Revenue was up 72.9% from 2026-03-31 to 2026-06-30. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
CGON currently screens at market cap $4.74B. NRG currently screens at market cap $27.88B and trailing P/E 145.2.
Not investment advice. Open the CGON and NRG stock pages for the full models.
Not investment advice.